Skip to main content
Equibles
QURE logo

QURE · uniQure N.V.

Track QURE — free

Use QURE with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$44.50 -0.36 (-0.80%) At close · Sep 4
Rebalance outlook locked
Market Cap
$2.83B
Shares
63.07M

QURE metrics

65 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$44.50
Market cap
$2.83B

Price action

19 metrics
Price change (1W)
-8.7%
Price change (30D)
-1.9%
Price change (3M)
+68.2%
Price change (6M)
+211.8%
Price change (YTD)
+86.0%
Price change (1Y)
+151.0%
Trailing year
Price change (5Y)
+43.0%
52-week high
$70.59
52-week low
$9.03
Change from 52-week high
-37.0%
Change from 52-week low
+392.8%
Annualized volatility
284.0%
Beta
-0.3
RSI (14D)
43.7
Price vs SMA 50
+0.2%
Price vs SMA 200
+57.0%
Avg volume (3M)
1.83M
Relative volume
0.5
Average dollar volume
$80.63M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
63.07M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
156.4×
reciprocal yield 0.6%
P / book
18.9
reciprocal yield 5.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
14.3×
reciprocal yield 7.0%
EV / revenue historical average (5Y)
11.9×
reciprocal yield 8.4%
EV / EBIT historical average (3Y)
2.4×
reciprocal yield 42.0%
EV / EBIT historical average (5Y)
2.4×
reciprocal yield 42.0%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
90.6%
Operating margin
-1,059.7%
Trailing 12 months
Net margin
-1,154.4%
Gross profit (TTM)
—
Operating profit (TTM)
−$191.74M
Net income (TTM)
−$208.87M
Trailing 12 months
Diluted EPS (TTM)
$-3.49
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.16

Growth

11 metrics
Revenue growth YoY
+127.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$18.09M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+18.1%
Year over year · more shares
Revenue CAGR (3Y)
-46.7%
Revenue CAGR (5Y)
-15.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-139.9%
Return on assets
-26.8%
Debt / equity
—
Current ratio
10.4
EBITDA (TTM)
−$178.55M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-3.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$139.99M
Total assets
$778.71M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$172.11M
Capital expenditures (TTM)
—
R&D (TTM)
$133.71M
SG&A (TTM)
$74.62M
Stock compensation (TTM)
$18.36M
R&D / revenue
739.0%
Stock compensation / revenue
101.5%

Ownership (13F)

3 metrics
13F filers
260
13F filer change QoQ
+38
Institutional ownership
122.5%

Short interest

3 metrics
Short interest
17.1%
Latest settlement · 9.8 days to cover
Days to cover
9.8d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$16.74M
Insider-sentiment score
20 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1590560 CUSIP N90064101 13F (30d) 211 filings 209 filers Visit website Investor relations